With Strong Uptake and Reimbursement, WashU's GPS Launches Expanded Cancer, Cardiomyopathy Panels | GenomeWeb

The Genomics and Pathology Services Laboratory at Washington University in St. Louis has expanded its next-generation sequencing clinical cancer panel and recently launched a cardiomyopathy panel, following success with its initial 28-gene cancer panel.

The CLIA certified and CAP accredited laboratory within Wash U's School of Medicine initially broke into the clinical sequencing field in 2011 with a 28-gene cancer panel that it ran on Illumina's HiSeq 2000.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.